Cargando…

Chemosensitization as a Means to Augment Commercial Antifungal Agents

Antimycotic chemosensitization and its mode of action are of growing interest. Currently, use of antifungal agents in agriculture and medicine has a number of obstacles. Foremost of these is development of resistance or cross-resistance to one or more antifungal agents. The generally high expense an...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Bruce C., Chan, Kathleen L., Kim, Jong H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289909/
https://www.ncbi.nlm.nih.gov/pubmed/22393330
http://dx.doi.org/10.3389/fmicb.2012.00079
_version_ 1782224915586351104
author Campbell, Bruce C.
Chan, Kathleen L.
Kim, Jong H.
author_facet Campbell, Bruce C.
Chan, Kathleen L.
Kim, Jong H.
author_sort Campbell, Bruce C.
collection PubMed
description Antimycotic chemosensitization and its mode of action are of growing interest. Currently, use of antifungal agents in agriculture and medicine has a number of obstacles. Foremost of these is development of resistance or cross-resistance to one or more antifungal agents. The generally high expense and negative impact, or side effects, associated with antifungal agents are two further issues of concern. Collectively, these problems are exacerbated by efforts to control resistant strains, which can evolve into a treadmill of higher dosages for longer periods. This cycle in turn, inflates cost of treatment, dramatically. A further problem is stagnation in development of new and effective antifungal agents, especially for treatment of human mycoses. Efforts to overcome some of these issues have involved using combinations of available antimycotics (e.g., combination therapy for invasive mycoses). However, this approach has had inconsistent success and is often associated with a marked increase in negative side effects. Chemosensitization by natural compounds to increase effectiveness of commercial antimycotics is a somewhat new approach to dealing with the aforementioned problems. The potential for safe natural products to improve antifungal activity has been observed for over three decades. Chemosensitizing agents possess antifungal activity, but at insufficient levels to serve as antimycotics, alone. Their main function is to disrupt fungal stress response, destabilize the structural integrity of cellular and vacuolar membranes or stimulate production of reactive oxygen species, augmenting oxidative stress and apoptosis. Use of safe chemosensitizing agents has potential benefit to both agriculture and medicine. When co-applied with a commercial antifungal agent, an additive or synergistic interaction may occur, augmenting antifungal efficacy. This augmentation, in turn, lowers effective dosages, costs, negative side effects and, in some cases, countermands resistance.
format Online
Article
Text
id pubmed-3289909
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-32899092012-03-05 Chemosensitization as a Means to Augment Commercial Antifungal Agents Campbell, Bruce C. Chan, Kathleen L. Kim, Jong H. Front Microbiol Microbiology Antimycotic chemosensitization and its mode of action are of growing interest. Currently, use of antifungal agents in agriculture and medicine has a number of obstacles. Foremost of these is development of resistance or cross-resistance to one or more antifungal agents. The generally high expense and negative impact, or side effects, associated with antifungal agents are two further issues of concern. Collectively, these problems are exacerbated by efforts to control resistant strains, which can evolve into a treadmill of higher dosages for longer periods. This cycle in turn, inflates cost of treatment, dramatically. A further problem is stagnation in development of new and effective antifungal agents, especially for treatment of human mycoses. Efforts to overcome some of these issues have involved using combinations of available antimycotics (e.g., combination therapy for invasive mycoses). However, this approach has had inconsistent success and is often associated with a marked increase in negative side effects. Chemosensitization by natural compounds to increase effectiveness of commercial antimycotics is a somewhat new approach to dealing with the aforementioned problems. The potential for safe natural products to improve antifungal activity has been observed for over three decades. Chemosensitizing agents possess antifungal activity, but at insufficient levels to serve as antimycotics, alone. Their main function is to disrupt fungal stress response, destabilize the structural integrity of cellular and vacuolar membranes or stimulate production of reactive oxygen species, augmenting oxidative stress and apoptosis. Use of safe chemosensitizing agents has potential benefit to both agriculture and medicine. When co-applied with a commercial antifungal agent, an additive or synergistic interaction may occur, augmenting antifungal efficacy. This augmentation, in turn, lowers effective dosages, costs, negative side effects and, in some cases, countermands resistance. Frontiers Research Foundation 2012-02-29 /pmc/articles/PMC3289909/ /pubmed/22393330 http://dx.doi.org/10.3389/fmicb.2012.00079 Text en Copyright © 2012 Campbell, Chan and Kim. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited.
spellingShingle Microbiology
Campbell, Bruce C.
Chan, Kathleen L.
Kim, Jong H.
Chemosensitization as a Means to Augment Commercial Antifungal Agents
title Chemosensitization as a Means to Augment Commercial Antifungal Agents
title_full Chemosensitization as a Means to Augment Commercial Antifungal Agents
title_fullStr Chemosensitization as a Means to Augment Commercial Antifungal Agents
title_full_unstemmed Chemosensitization as a Means to Augment Commercial Antifungal Agents
title_short Chemosensitization as a Means to Augment Commercial Antifungal Agents
title_sort chemosensitization as a means to augment commercial antifungal agents
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289909/
https://www.ncbi.nlm.nih.gov/pubmed/22393330
http://dx.doi.org/10.3389/fmicb.2012.00079
work_keys_str_mv AT campbellbrucec chemosensitizationasameanstoaugmentcommercialantifungalagents
AT chankathleenl chemosensitizationasameanstoaugmentcommercialantifungalagents
AT kimjongh chemosensitizationasameanstoaugmentcommercialantifungalagents